Promega Corporation

Aurora B Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human Aurora B was expressed by baculovirus in Sf9 cells using an N-terminal GST tag. Aurora B is a member of the Aurora kinase family that associates with microtubules during chromosome movement and segregation. Aurora B localizes to the microtubules near kinetochores, specifically to the specialized microtubules called K-fibers. Aurora B inhibits the microtubule depolymerizing activity of mitotic centromere-associated kinesin (MCAK) by phosphorylating MCAK on Ser92. This phosphorylation also regulates MCAK translocalization from kinetochores to the centromer...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for customers of Promega AG only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

Aurora B Kinase Enzyme System

Close Window

Aurora B Kinase Enzyme System

 Components

10μg
- V3971 CHF 527.00 Add to cart

Aurora B Kinase Enzyme System

Close Window

Aurora B Kinase Enzyme System

 Components

1mg
- V3972 CHF 8 386.00 Add to cart

ADP-Glo™ Kinase Assay + Aurora B Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + Aurora B Kinase Enzyme System

 Components

  • Aurora B Kinase Enzyme System

    V39711 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9181 CHF 1 302.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V3971, V3972, V9181 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V9181 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V9181 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V9181 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V9181 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V9181 U.S. Pat. No. 8,183,007 and other patents pending.

V9181 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V9181 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

Prefer a different language?

Your country is set to Switzerland. Your language is set to English. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.